Open Access UCL Research: Cost Effectiveness of Support for People Starting a New Medication for a Long-Term Condition Through Community Pharmacies: An Economic Evaluation of the New Medicine Service (NMS) Compared with Normal Practice https://t.co/aMBZVyD
RT @PECjournal: 2nd most downloaded paper in @PECjournal for 2018 is a paper by @RachelElliott67 et al. from @HealthEcon_MCR on cost effect…
RT @PECjournal: 2nd most downloaded paper in @PECjournal for 2018 is a paper by @RachelElliott67 et al. from @HealthEcon_MCR on cost effect…
RT @PECjournal: 2nd most downloaded paper in @PECjournal for 2018 is a paper by @RachelElliott67 et al. from @HealthEcon_MCR on cost effect…
RT @PECjournal: 2nd most downloaded paper in @PECjournal for 2018 is a paper by @RachelElliott67 et al. from @HealthEcon_MCR on cost effect…
2nd most downloaded paper in @PECjournal for 2018 is a paper by @RachelElliott67 et al. from @HealthEcon_MCR on cost effectiveness of UK New Medicine Service https://t.co/ZTk8oq22O6
Cost Effectiveness of Support for People Starting a New Medication for a Long-Term Condition Through Community Pharmacies: An Economic Evaluation of the New Medicine Service (NMS) Compared with... https://t.co/HIYOsctW1k
@mikakorte Mitä mieltä olet tästä paperista? Voisiko tuoda säästöjä myös meillä? https://t.co/16bF2M4TM1
NMS is cost effective but under-utilised service. #GPPharmacists are well placed to refer & better integrate service https://t.co/cdEMFX0g1J
RT @kamleshkhunti: Pharmacy based New Medicine Service for long term conditions is Cost Effective https://t.co/pdavNZMKRR @PNewlandJones @…
RT @kamleshkhunti: Pharmacy based New Medicine Service for long term conditions is Cost Effective https://t.co/pdavNZMKRR @PNewlandJones @…
RT @kamleshkhunti: Pharmacy based New Medicine Service for long term conditions is Cost Effective https://t.co/pdavNZMKRR @PNewlandJones @…
RT @kamleshkhunti: Pharmacy based New Medicine Service for long term conditions is Cost Effective https://t.co/pdavNZMKRR @PNewlandJones @…
Pharmacy based New Medicine Service for long term conditions is Cost Effective https://t.co/pdavNZMKRR @PNewlandJones @grahamsphillips
I'm reading this on #springerlink https://t.co/Gmy5KrcAvK
Pharmacy service could save millions of UK Pounds: •A team of health economists has found that millions of UK... https://t.co/IcDciRYm8j
RT @GaryParagpuri: Just seen this study that says pharmacy's NMS service can save £500m pa for NHS. https://t.co/b7M0EwZyLJ
I'm reading this on #springerlink https://t.co/cYy83QnOvV Positive evidence of value #communitypharmacy NMS
RT @JohanWaller: Ny studie som visar på värdet när apotek ger stöd vid nyinsättning av läkemedelsbehandling. https://t.co/1jTHJOGscV
【PharmacoEconomics】 Cost Effectiveness of Support for People Starting a New Medication for a Long-Term Condition .. https://t.co/MUOT9uDETR
RT @JohanWaller: Ny studie som visar på värdet när apotek ger stöd vid nyinsättning av läkemedelsbehandling. https://t.co/1jTHJOGscV
RT @NHFTNHSLibrary: £500m could be saved by ‘new medicine service’ for people with a long-term condition: economic evaluation study https:/…
RT @NHFTNHSLibrary: £500m could be saved by ‘new medicine service’ for people with a long-term condition: economic evaluation study https:/…
A report from @ucl @UniofNottingham & @OfficialUoM thinks £500m could be saved by the NHS' new medicine service: https://t.co/mq2kDm0UzL https://t.co/6SVw2dwBpN
Medisinstart er kost.effektivt viser engelsk forskning. https://t.co/06M1dmRlgq
Evidence for cost effectiveness of New Medicines Service #pharmacy https://t.co/62wkhGTh8j
RT @JohanWaller: Ny studie som visar på värdet när apotek ger stöd vid nyinsättning av läkemedelsbehandling. https://t.co/1jTHJOGscV
RT @JohanWaller: Ny studie som visar på värdet när apotek ger stöd vid nyinsättning av läkemedelsbehandling. https://t.co/1jTHJOGscV
RT @JohanWaller: Ny studie som visar på värdet när apotek ger stöd vid nyinsättning av läkemedelsbehandling. https://t.co/1jTHJOGscV
RT @JohanWaller: Ny studie som visar på värdet när apotek ger stöd vid nyinsättning av läkemedelsbehandling. https://t.co/1jTHJOGscV
Ny studie som visar på värdet när apotek ger stöd vid nyinsättning av läkemedelsbehandling. https://t.co/1jTHJOGscV
RT @NHFTNHSLibrary: £500m could be saved by ‘new medicine service’ for people with a long-term condition: economic evaluation study https:/…
£500m could be saved by ‘new medicine service’ for people with a long-term condition: economic evaluation study https://t.co/YlxIBco2KH
New study shows ‘new medicine service' could save £500m - through improved adherence, etc. https://t.co/FMdyxnoCA8
Wow, I knew NMS had the potential to make a difference - ongoing economic impacts are much bigger than I expected! https://t.co/4zpqBfXqhT
@pharmthorrun @tomgregory87 https://t.co/PGi5mCD8Qt Some evidence nms works. Sorry to intrude! #nms #pharmacy #communitypharmacy #research
The article itself can be found here https://t.co/dKHSqm3igv
RT @RachelElliott67: Improving patient outcomes, saving NHS money, with a community-pharmacy theoretically-driven low-cost intervention htt…
RT @RachelElliott67: Improving patient outcomes, saving NHS money, with a community-pharmacy theoretically-driven low-cost intervention htt…
RT @RachelElliott67: Improving patient outcomes, saving NHS money, with a community-pharmacy theoretically-driven low-cost intervention htt…
RT @RachelElliott67: Improving patient outcomes, saving NHS money, with a community-pharmacy theoretically-driven low-cost intervention htt…
RT @RachelElliott67: Improving patient outcomes, saving NHS money, with a community-pharmacy theoretically-driven low-cost intervention htt…
RT @RachelElliott67: Improving patient outcomes, saving NHS money, with a community-pharmacy theoretically-driven low-cost intervention htt…
RT @RachelElliott67: Improving patient outcomes, saving NHS money, with a community-pharmacy theoretically-driven low-cost intervention htt…
If you choose the 10 week primary outcome measure rather than the 6 week (or 26 week if it had been published) primary outcome measures https://t.co/8roiYdtU2r
Definitely worth a read! https://t.co/m5CL4FyZya
RT @RachelElliott67: Improving patient outcomes, saving NHS money, with a community-pharmacy theoretically-driven low-cost intervention htt…
RT @RachelElliott67: Improving patient outcomes, saving NHS money, with a community-pharmacy theoretically-driven low-cost intervention htt…
Improving patient outcomes, saving NHS money, with a community-pharmacy theoretically-driven low-cost intervention https://t.co/DtWyAJBz5d
#HealthEconJA Cost Effectiveness of Support for People Starting a New Medication for a Long-Term Condition Through… https://t.co/dyRSmfnPfk